BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 9568428)

  • 21. [Multiple skin and mouth squamous cell carcinomas related to long-term treatment with hydroxyurea].
    Estève E; Georgescu V; Heitzmann P; Martin L
    Ann Dermatol Venereol; 2001 Sep; 128(8-9):919-21. PubMed ID: 11590345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Cutaneous side effects of a long-term treatment by hydroxyurea].
    Steels E; Heenen M; Germaux MA; Moens JP
    Rev Med Brux; 2006; 27(1):39-41. PubMed ID: 16608010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metastatic squamous cell carcinoma of the skin in chronic myeloid leukaemia: complication of hydroxyurea therapy.
    Pamuk GE; Turgut B; Vural O; Demir M; Tek M; Altaner S
    Clin Lab Haematol; 2003 Oct; 25(5):329-31. PubMed ID: 12974726
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple cutaneous precanceroses and carcinomas from combined iatrogenic/professional exposure to arsenic.
    Torchia D; Massi D; Caproni M; Fabbri P
    Int J Dermatol; 2008 Jun; 47(6):592-3. PubMed ID: 18477152
    [No Abstract]   [Full Text] [Related]  

  • 25. Procarbazine (Natulan) and busulfan in the treatment of polycythemia vera.
    Penttilä O; Ikkala E
    Ann Med Intern Fenn; 1968; 57(2):99-101. PubMed ID: 5706392
    [No Abstract]   [Full Text] [Related]  

  • 26. Busulfan versus hydroxyurea in the treatment of polycythemia vera (PV) and essential thrombocythemia (ET).
    Brodsky I
    Am J Clin Oncol; 1998 Feb; 21(1):105-6. PubMed ID: 9499248
    [No Abstract]   [Full Text] [Related]  

  • 27. From efficacy to safety: a Polycythemia Vera Study group report on hydroxyurea in patients with polycythemia vera.
    Fruchtman SM; Mack K; Kaplan ME; Peterson P; Berk PD; Wasserman LR
    Semin Hematol; 1997 Jan; 34(1):17-23. PubMed ID: 9025158
    [No Abstract]   [Full Text] [Related]  

  • 28. Leukemic transformation of polycythemia vera after treatment with hydroxyurea with abnormalities of chromosome 17.
    Tóthová E; Fricová M; Stecová N; Hlebasková M; Kafková A; Raffac S; Guman T; Svorcová E; Nebesnáková E
    Neoplasma; 2001; 48(5):389-92. PubMed ID: 11845984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arsenic and skin cancer: cocarcinogenicity.
    Spoor HJ
    Cutis; 1976 Nov; 18(5):631-2. PubMed ID: 1022414
    [No Abstract]   [Full Text] [Related]  

  • 30. Nonmelanoma skin cancer associated with Hydroxyurea treatment: Overview of the literature and our own experience.
    Cantisani C; Kiss N; Naqeshbandi AF; Tosti G; Tofani S; Cartoni C; Carmosino I; Cantoresi F
    Dermatol Ther; 2019 Sep; 32(5):e13043. PubMed ID: 31364787
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Painful leg ulcers and a rash in a patient with polycythaemia rubra vera. Diagnosis: hydroxyurea-induced leg ulceration and dermatomyositis-like skin changes.
    Haniffa MA; Speight EL
    Clin Exp Dermatol; 2006 Sep; 31(5):733-4. PubMed ID: 16901329
    [No Abstract]   [Full Text] [Related]  

  • 32. Perimalleolar ulcers in hydroxyurea treated patients with concomitant chronic venous disease: diagnostic pitfalls.
    Jain V; Gupta K; Nagpal N
    J Coll Physicians Surg Pak; 2005 Oct; 15(10):658-60. PubMed ID: 19810313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Secondary cutaneous effects of hydroxyurea: prospective study of 26 patients from a dermatologic consultation].
    Salmon-Ehr V; Leborgne G; Vilque JP; Potron G; Bernard P
    Rev Med Interne; 2000 Jan; 21(1):30-4. PubMed ID: 10685452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hydroxyurea-induced pneumonitis].
    Schwonzen M; Spangenberger H; Spengler M
    Med Klin (Munich); 2003 Jul; 98(7):394-7. PubMed ID: 12937905
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Arsenical keratoses and carcinomas].
    Fumal I; Piérard-Franchimont C; Piérard GE
    Rev Med Liege; 2005 Apr; 60(4):217-21. PubMed ID: 15943097
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Skin tumours in immunosuppressed patients.
    Marshall VC
    Aust N Z J Surg; 1973 Dec; 43(3):214-22. PubMed ID: 4618104
    [No Abstract]   [Full Text] [Related]  

  • 37. Antineutrophil cytoplasmic antibody-associated vasculitis in a patient with polycythemia vera after long-term hydroxyurea treatment.
    Su L; Zheng J; Xiu L; Li J; Ding M; He W
    Leuk Lymphoma; 2011 Nov; 52(11):2193-4. PubMed ID: 21718133
    [No Abstract]   [Full Text] [Related]  

  • 38. Arsenic as a cause of skin cancer, with notes on its occurrence in Pretoria.
    Schulz EJ
    S Afr Med J; 1967 Sep; 41(33):819-22. PubMed ID: 6060318
    [No Abstract]   [Full Text] [Related]  

  • 39. [Treatment of polycythemia. II.--Comparison of hydroxyurea with pipobroman in 294 patients less than 65 years of age].
    Najean Y; Rain JD; Lejeune F; Echard M; Fermand JP; Gruyer P; Brahimi S
    Ann Med Interne (Paris); 1998 Mar; 149(2):94-100. PubMed ID: 11490531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr virus-positive mucocutaneous ulcer in a patient with polycythemia vera treated with oral hydroxyurea.
    Hamada T; Kawata M; Maeda Y; Yoshino T; Miyake T; Morizane S; Hirai Y; Iwatsuki K
    J Dermatol; 2018 Apr; 45(4):e82-e83. PubMed ID: 29139148
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.